Maximus (NYSE:MMS) Hits New 1-Year Low – What’s Next?

Maximus, Inc. (NYSE:MMS)’s stock price hit a new 52-week low during trading on Thursday . The stock traded as low as $62.51 and last traded at $62.6150, with a volume of 718750 shares changing hands. The stock had previously closed at $64.10.

Analyst Ratings Changes

Several research firms recently issued reports on MMS. Weiss Ratings lowered shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Finally, Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Monday, February 23rd. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy”.

Maximus Trading Down 2.3%

The company has a market capitalization of $3.42 billion, a price-to-earnings ratio of 9.53 and a beta of 0.63. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. The business’s 50 day moving average price is $77.21 and its two-hundred day moving average price is $83.77.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, equities analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Friday, February 13th. This is a boost from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is currently 20.09%.

Insider Buying and Selling at Maximus

In other Maximus news, CEO Bruce Caswell bought 3,175 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The shares were acquired at an average cost of $78.45 per share, for a total transaction of $249,078.75. Following the transaction, the chief executive officer directly owned 328,013 shares in the company, valued at approximately $25,732,619.85. This represents a 0.98% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David Mutryn purchased 1,000 shares of the firm’s stock in a transaction on Monday, February 9th. The stock was acquired at an average price of $75.62 per share, with a total value of $75,620.00. Following the completion of the transaction, the chief financial officer owned 40,037 shares in the company, valued at approximately $3,027,597.94. This trade represents a 2.56% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 1.80% of the company’s stock.

Institutional Trading of Maximus

Several institutional investors have recently modified their holdings of the business. Royal Bank of Canada lifted its holdings in Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after buying an additional 11,716 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Maximus by 7.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after acquiring an additional 11,754 shares during the period. Jane Street Group LLC boosted its holdings in Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after acquiring an additional 88,835 shares during the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Maximus during the 2nd quarter valued at approximately $204,000. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.